tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Medtide Inc. Gains CSRC Approval for H Share Full Circulation

Story Highlights
Medtide Inc. Gains CSRC Approval for H Share Full Circulation

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

Medtide, Inc. Class H ( (HK:3880) ) just unveiled an update.

Medtide Inc., a joint stock company incorporated in China, announced that the China Securities Regulatory Commission (CSRC) has accepted its application for the full circulation of its H shares. This move involves converting approximately 48.10% of its unlisted shares into H shares, which will then be listed on the Hong Kong Stock Exchange. The conversion and listing process is subject to various regulatory approvals, and shareholders are advised to exercise caution.

More about Medtide, Inc. Class H

Average Trading Volume: 1,047,483

For a thorough assessment of 3880 stock, go to TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1